KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,388 | -31.3% | 19,884 | +13.7% | 0.00% | – |
| Q2 2023 | $402,187 | -46.1% | 17,494 | -30.6% | 0.00% | – |
| Q1 2023 | $746,705 | +42.6% | 25,201 | +20.1% | 0.00% | – |
| Q4 2022 | $523,686 | +50.5% | 20,981 | +31.3% | 0.00% | – |
| Q3 2022 | $348,000 | -12.3% | 15,976 | -20.8% | 0.00% | – |
| Q2 2022 | $397,000 | -71.9% | 20,176 | -39.5% | 0.00% | -100.0% |
| Q1 2022 | $1,412,000 | -37.3% | 33,366 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $2,251,000 | +7.6% | 35,450 | -0.5% | 0.00% | 0.0% |
| Q3 2021 | $2,092,000 | +125.9% | 35,619 | +86.5% | 0.00% | – |
| Q2 2021 | $926,000 | +250.8% | 19,100 | +181.0% | 0.00% | – |
| Q1 2021 | $264,000 | -42.6% | 6,798 | -8.3% | 0.00% | – |
| Q4 2020 | $460,000 | – | 7,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |